References
- Wallmark B, Berglindh T, Mårdh S, et al. The mechanism of action of omeprazole. Scand J Gastroenterol 1985; 20(suppl 108)37–51
- Larsson H, Mattsson H, Sundell G, Carlsson E. Animal pharmacodynamics of omeprazole. A survey of the pharmacological properties of omeprazole in animals. Scand J Gastroenterol 1985; 20(suppl 108)23–35
- Erickson G EM. 1980, Unpublished results
- Blythe R H, Grass G M, MacDonell D R. The formulation and evaluation of enteric-coated aspirin tablets. Am J Pharm 1959; 131: 206–16
- Bogentoft C, Carlsson I, Ekenved G, Magnusson A. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. Eur J Clin Pharmacol 1978; 14: 351–5
- Bechgaard H. Critical factors influencing gastrointestinal absorption—What is the role of pellets?. Acta Pharm Technolog 1982; 28: 149–57
- Bogentoft C, Jonsson U E, Eriksson R, Alpsten M. Gastric emptying of pellets and tablets in healthy subjects under fasting and nonfasting conditions. 43rd International Congress of Pharmaceutical Sciences FIP, Montreux, 1983, 102
- Levy G, Hayes B A. Physicochemical basis of the buffered acetylsalicylic acid controversy. N Engl J Med 1960; 262: 1053–8
- Persson B-A, Lagerström P-O, Grundevik I. Determination of omeprazole and metabolites in plasma and urine. Scand J Gastroenterol 1985; 20(suppl 108)71–7
- Cederberg C, Ekenved G, Lind T, Olbe L. Acid inhibitory characteristics of omeprazole in man. Scand J Gastroenterol 1985; 20(suppl 108)105–12